WISCON Pharmaceuticals, as a strategy will market the following products.
With the advent of Molecular Markers for antimalarial resistance, Wiscon is ready right now with WHO’s latest recommendations of Molecules to reduce mortality and morbidity from the dreaded disease of Malaria.
RTSUN SP TABLETS (COMBIPACK) - SHORT TERM 3 DAYS COMBIPACK THERAPY FOR RESISTANT CASES OF FALCIPARUM MALARIA AS RECOMMENDED BY WHO.
Each Combikit contains :
2 Sulphadoxine each of 500 mg tabs and
2 Pyrimethamine each of 25 mg tablets +
6 artesunate each of 100 mg tablets With distinguising colours in strip with day/s Marked separately in different colours.